| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |